Author

Dale Song

Observed name: D. Song

Institution: Celgene (United States)

Observed institution: Celgene (United States)

OpenAlex ID: A5029485394

A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

2017 · Myron S. Czuczman, Marek Trněný, et al. · Clinical Cancer Research · 162

A Phase 2/3 Multicenter, Randomized Study Comparing the Efficacy and Safety of Lenalidomide Versus Investigator’s Choice in Relapsed/Refractory DLBCL

2014 · Myron S. Czuczman, Andrew Davies, et al. · Blood · 20

A multicenter randomized phase II trial on Kanglaite Injection (KLT) plus gemcitabine hydrochloride (GEM) versus GEM in patients with local advanced and metastatic pancreatic cancer.

2011 · Y. Sun, Y. Li, et al. · Journal of Clinical Oncology · 8

Works count: 3

Citation count: 190

H-index: 3

I10-index: 2